Artwork

Content provided by Bobby Scott, Sandy Robertson, and Dawn Caviness. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bobby Scott, Sandy Robertson, and Dawn Caviness or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#8 Buprenorphine-Naloxone for Opioid Use Disorder - Bobby Levy, MD

40:44
 
Share
 

Manage episode 388407182 series 3428533
Content provided by Bobby Scott, Sandy Robertson, and Dawn Caviness. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bobby Scott, Sandy Robertson, and Dawn Caviness or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

"One drug, three doses, one test.” In this episode of 'What's the Proof?', we are joined by our guest, Dr. Bobby Levy, who will be discussing the application of buprenorphine-naloxone in the treatment of opioid use disorder. Discover how personal experiences led Dr. Levy to become a passionate advocate for integrating opioid use disorder treatment into primary care. Gain insights into the robust evidence supporting the use of buprenorphine, its practical dosing and initiation, and Dr. Levy's compelling counterpoints to common criticisms. This episode offers a unique perspective for any physician keen on confronting the opioid epidemic. Listen in and find out how you can make a life-saving impact in your community.

Episode Outline:

  • Opening remarks - 00:35
  • Introducing Dr. Levy and his journey to OBOT - 02:31
  • The role of Primary Care Providers in OBOT - 09:42
  • Evidence supporting buprenorphine-naloxone - 12:46
  • Debunking the myth of "trading one addiction for another" - 20:52
  • Harm reduction model - 22:48
  • Potential challenges and downsides - 24:48
  • Dosing and initiation - 28:00
  • Key takeaways from interview - 33:26
  • Host reflections and closing - 35:46

Episode Links:

If you liked the episode, please follow us and tell your colleagues and friends!

Comments/Questions/Suggestions? Email us at whatstheproofpodcast@gmail.com or find us on X @theproofpodcast!

Credits:

  • Hosts: Bobby Scott, MD, FAAFP; Sandy Robertson, PharmD; Dawn Caviness, MD, BSN
  • Production & Cover Art: Bobby Scott, MD, FAAFP
  • Music: Twisterium, MondayHopes, Muzaproduction, and SergeQuadrado from Pixabay
  continue reading

10 episodes

Artwork
iconShare
 
Manage episode 388407182 series 3428533
Content provided by Bobby Scott, Sandy Robertson, and Dawn Caviness. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bobby Scott, Sandy Robertson, and Dawn Caviness or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

"One drug, three doses, one test.” In this episode of 'What's the Proof?', we are joined by our guest, Dr. Bobby Levy, who will be discussing the application of buprenorphine-naloxone in the treatment of opioid use disorder. Discover how personal experiences led Dr. Levy to become a passionate advocate for integrating opioid use disorder treatment into primary care. Gain insights into the robust evidence supporting the use of buprenorphine, its practical dosing and initiation, and Dr. Levy's compelling counterpoints to common criticisms. This episode offers a unique perspective for any physician keen on confronting the opioid epidemic. Listen in and find out how you can make a life-saving impact in your community.

Episode Outline:

  • Opening remarks - 00:35
  • Introducing Dr. Levy and his journey to OBOT - 02:31
  • The role of Primary Care Providers in OBOT - 09:42
  • Evidence supporting buprenorphine-naloxone - 12:46
  • Debunking the myth of "trading one addiction for another" - 20:52
  • Harm reduction model - 22:48
  • Potential challenges and downsides - 24:48
  • Dosing and initiation - 28:00
  • Key takeaways from interview - 33:26
  • Host reflections and closing - 35:46

Episode Links:

If you liked the episode, please follow us and tell your colleagues and friends!

Comments/Questions/Suggestions? Email us at whatstheproofpodcast@gmail.com or find us on X @theproofpodcast!

Credits:

  • Hosts: Bobby Scott, MD, FAAFP; Sandy Robertson, PharmD; Dawn Caviness, MD, BSN
  • Production & Cover Art: Bobby Scott, MD, FAAFP
  • Music: Twisterium, MondayHopes, Muzaproduction, and SergeQuadrado from Pixabay
  continue reading

10 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide